BNTC

Benitec Biopharma Inc.

Healthcare · Biotechnology

$169.27 sample

+2.63 (+1.58%) 1D

Market cap

$725.5B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-30

Alerts

8

Price$169.27 +12.85% 3M daily closessample

169.27148.75

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30SEC8-K filed: material event
Sep 24SECDEF 14A filed
Sep 18INSInsider sell: Chief Financial Officer
Sep 11INSInsider buy: 10% owner
Sep 03INSInsider sell: 10% owner
Aug 27SECForm 144 filed
Aug 21SEC10-Q filed
Aug 14INSInsider sell: Chief Executive Officer

Sign up to see the real BNTC record →

Company facts

SEC EDGAR registration

Name: Benitec Biopharma Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +3sample, -100 to +100
Reporting currency: USD

Who is positioning in BNTC

sample

Insiders: 13 insider transactions over 90 days, net selling, $12.8M
Congress: 4 members traded over 90 days
Institutions · 13F: 6 funds hold $5.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$26.9B +19.5% y/y

Q4 2024Q3 2026

Inventory$15.9B +17.2% y/y

Q4 2024Q3 2026

Accounts receivable$11.8B +14.5% y/y

Q4 2024Q3 2026

Total debt$31.8B +19.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $629.6B -5.2% 3M
Sample peer B: $393.4B +14.1% 3M
Sample peer C: $189.0B +1.3% 3M
Sample peer D: $705.1B +2.9% 3M
Sample peer E: $443.7B -8.9% 3M